These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12470704)

  • 41. Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes.
    Fleuranceau-Morel P; Barrier L; Fauconneau B; Piriou A; Huguet F
    Neurosci Lett; 1999 Dec; 277(2):91-4. PubMed ID: 10624817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The functional recovery of damaged brain: the effect of GM1 monosialoganglioside.
    Toffano G; Savoini G; Aporti F; Calzolari S; Consolazione A; Maura G; Marchi M; Raiteri M; Agnati LF
    J Neurosci Res; 1984; 12(2-3):397-408. PubMed ID: 6150119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ganglioside GM1 protects cAMP 3'5':phosphodiesterase from inactivation caused by lipid peroxidation in brain synaptosomes of rats.
    Tyurina YY; Tyurin VA; Avrova NF
    Mol Chem Neuropathol; 1993 Aug; 19(3):205-17. PubMed ID: 8397583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct visualization of the lateral structure of giant vesicles composed of pseudo-binary mixtures of sulfatide, asialo-GM1 and GM1 with POPC.
    Rodi PM; Maggio B; Bagatolli LA
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):544-555. PubMed ID: 29106974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new in vitro approach for investigating the MPTP effect on DA uptake.
    Barc S; Page G; Fauconneau B; Barrier L; Huguet F
    Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes.
    Desce JM; Godeheu G; Galli T; Glowinski J; Chéramy A
    Brain Res; 1994 Mar; 640(1-2):205-14. PubMed ID: 7911726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of sialic acid in high-affinity uptake of dopamine by synaptosomes from rat brain.
    Zaleska MM; Erecińska M
    Neurosci Lett; 1987 Nov; 82(1):107-12. PubMed ID: 3696480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats.
    Galici R; Galli A; Jones DJ; Sanchez TA; Saunders C; Frazer A; Gould GG; Lin RZ; France CP
    Neuroendocrinology; 2003 Feb; 77(2):132-40. PubMed ID: 12624535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute L-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice.
    Naudin B; Bonnet JJ; Costentin J
    Brain Res; 1995 Dec; 701(1-2):151-7. PubMed ID: 8925278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of chemically induced changes in synaptosomal membrane order by ganglioside GM1 and alpha-tocopherol.
    Bondy SC; McKee M; Davoodbhoy YM
    Biochim Biophys Acta; 1990 Jul; 1026(2):213-9. PubMed ID: 1696128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes.
    Campbell AD; Womer DE; Simon JR
    Eur J Pharmacol; 1995 Jul; 290(2):157-62. PubMed ID: 8575531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GM1 ganglioside enhances Ret signaling in striatum.
    Newburn EN; Duchemin AM; Neff NH; Hadjiconstantinou M
    J Neurochem; 2014 Aug; 130(4):541-54. PubMed ID: 24821093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acrylamide inhibits dopamine uptake in rat striatal synaptic vesicles.
    LoPachin RM; Barber DS; He D; Das S
    Toxicol Sci; 2006 Jan; 89(1):224-34. PubMed ID: 16207938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of aromatic L-amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists.
    Zhu MY; Juorio AV; Paterson IA; Boulton AA
    Br J Pharmacol; 1994 May; 112(1):23-30. PubMed ID: 7913379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Motoric behavior in aged rats treated with GM1.
    Goettl VM; Wemlinger TA; Colvin AE; Neff NH; Hadjiconstantinou M
    Brain Res; 2001 Jul; 906(1-2):92-100. PubMed ID: 11430865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
    Wells GB; Lopez MC; Tanaka JC
    Brain Res Bull; 1999 Apr; 48(6):641-7. PubMed ID: 10386845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cortical ablation and drug-induced changes in striatal ascorbic acid oxidation and behavior in the rat.
    Miele M; Enrico P; Esposito G; Fresu L; Migheli R; De Natale G; Desole MS
    Pharmacol Biochem Behav; 1995 Jan; 50(1):1-7. PubMed ID: 7700944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine and gamma-aminobutyric acid transporters: differential regulation by agents that promote phosphorylation.
    Tian Y; Kapatos G; Granneman JG; Bannon MJ
    Neurosci Lett; 1994 May; 173(1-2):143-6. PubMed ID: 7936402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
    Mogg AJ; Whiteaker P; McIntosh JM; Marks M; Collins AC; Wonnacott S
    J Pharmacol Exp Ther; 2002 Jul; 302(1):197-204. PubMed ID: 12065717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.